期刊文献+

乙型肝炎肝硬化患者血清IL-10和可溶性细胞间黏附分子-1水平及其对疾病预后的判断价值 被引量:7

Changes of serum IL-10 and soluble intercellular adhesion molecule-1 levels in patients with hepatitis B-induced liver cirrhosis
下载PDF
导出
摘要 目的分析比较乙型肝炎肝硬化患者血清细胞因子水平变化及其与疾病进展的关系。方法2014年9月~2016年8月我院收治的79例乙型肝炎肝硬化患者,其中Child-PughA级31例,B级25例,C级23例,另选体检健康人23例作为对照,采用ELISA法检测血清IL-2、IL-6、IL-10和可溶性细胞间黏附分子-1(sICAM-1)。结果代偿期肝硬化和失代偿期肝硬化患者血清IL-10水平水平分别为(43.5±8.4)g/L和(55.8±6.1)g/L,显著低于健康人【(247.1±43.4)g/L,P<0.01】,而血清IL-2、IL-6和sICAM-1水平分别为(148.1±21.3)g/L、(43.5±8.4)g/L和(298.5±85.7)ng/mL,和(180.6±17.1)g/L、(55.8±6.1)g/L和(685.4±164.8)ng/mL,均显著高于健康人【(22.6±6.0)g/L、(6.6±1.5)g/L和(158.7±21.5)ng/mL,P<0.05】;23例Child-PughC级患者血清IL-10水平为(84.3±11.4)g/L,显著低于31例Child-PughA级或25例Child-PughB级【分别为(121.3±14.6)g/L和(101.4±12.6)g/L;P<0.05】,而血清IL-2、IL-6和sICAM-1水平分别为(182.7±31.4)g/L、(57.3±7.3)g/L和(665.0±135.5)ng/mL,显著高于Child-PughA级或Child-PughB级【分别为(138.4±19.6)g/L、(42.4±6.6)g/L和(398.7±103.3)ng/mL,和(157.7±22.3)g/L、(49.9±6.2)g/L和(509.6±122.9)ng/mL,P<0.05】;肝硬化患者发生自发性细菌性腹膜炎、肝性脑病或消化道出血时,血清IL-10水平会进一步降低,而血清IL-2、IL-6和sICAM-1水平则进一步升高。结论乙型肝炎肝硬化患者血清细胞因子水平会随着疾病的变化而改变,了解这些变化对指导诊疗可能有帮助。 Objective To investigate the changes of serum IL-10 and soluble intercellular adhesion molecule-1(sICAM 1)levels in patients with hepatitis B-induced liver cirrhosis(LC).Methods A total of 79 patients with hepatitis B-induced LC,including 31 with Child-Pugh class A,25 with Child-Pugh class B and 23 with Child-Pugh class C,were enrolled in our hospital between September 2014 and August 2016,and 23 healthy persons were selected as control.Serum interleukin(IL)-2,IL-6,IL-10 and sICAM 1 levels were detected by enzyme-linked immunosorbent assay.Results Serum IL-10 levels in patients with compensated and decompensated LC were(43.5±8.4)g/L and(55.8±6.1)g/L,respectively,much lower than(247.1±43.4)g/L(P<0.01)in healthy persons,while serum IL-2,IL-6 and sICAM-1 levels were(148.1±21.3)g/L,(43.5±8.4)g/L and(298.5±85.7)ng/mL,and(180.6±17.1)g/L,(55.8±6.1)g/L and(685.4±164.8)ng/mL,respectively,significantly higher than(22.6±6.0)g/L,(6.6±1.5)g/L and(158.7±21.5)ng/mL in healthy control(P<0.05);serum IL-10 level in 23 patients with Child-Pugh class C was(84.3±11.4)g/L,much lower than(121.3±14.6)g/L in 31 patients with Child-Pugh class A or(101.4±12.6)g/L in 25 with Child-Pugh class B(P<0.05),while serum IL-2,IL-6 and sICAM-1 levels were(182.7±31.4)g/L,(57.3±7.3)g/L and(665.0±135.5)ng/mL,much higher than(138.4±19.6)g/L,(42.4±6.6)g/L and(398.7±103.3)ng/mL,in patients with Child-Pugh class A or(157.7±22.3)g/L,(49.9±6.2)g/L and(509.6±122.9)ng/mL in patients with Child-Pugh class B(all P<0.05);serum IL-10 levels decreased,while serum IL-2,IL-6 and sICAM-1 levels increased in patients with complications such as spontaneous bacterial peritonitis,hepatic encephalopathy or gastrointestinal bleeding.Conclusion Serum cytokine levels change as liver functions deteriorate,which might be helpful for clinicians to make managements in time in clinical practice.
作者 金军 宋震宇 刘吉祥 Jin Jun;Song Zhenyu;Liu Jixiang(Department of Gastroenterology,Central Hospital,Bazhong 636000,Sichuan Province,China)
出处 《实用肝脏病杂志》 CAS 2019年第4期549-552,共4页 Journal of Practical Hepatology
基金 四川省自然科学基金资助项目(编号:2017393)
关键词 肝硬化 乙型肝炎 可溶性细胞间黏附分子-1 白细胞介素-10 Liver cirrhosis Hepatitis B Soluble intercellular adhesion molecule-1 Interleukin-10
  • 相关文献

参考文献6

二级参考文献44

  • 1Zaigham Abbas,Rafia Afzal.Life cycle and pathogenesis of hepatitis D virus:A review[J].World Journal of Hepatology,2013,5(12):666-675. 被引量:9
  • 2梁坚,王婉梅,梁伟娟.肝硬化患者血清瘦素与肿瘤坏死因子变化的研究[J].中国医师杂志,2005,7(9):1263-1264. 被引量:5
  • 3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 4冯红萍.甲胎蛋白与血清铁蛋白联合检测在慢性乙型重症肝炎中的临床意义[J].现代诊断与治疗,2007,18(4):232-233. 被引量:11
  • 5JacquesFerlay,Hai‐RimShin,FreddieBray,DavidForman,ColinMathers,Donald MaxwellParkin.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int. J. Cancer . 2010 (12) 被引量:20
  • 6Kuniholm, Mark H,Lesi, Olufunmilayo A,Mendy, Maimuna,Akano, Aliu O,Sam, Omar,Hall, Andrew J,Whittle, Hilton,Bah, Ebrima,Goedert, James J,Hainaut, Pierre,Kirk, Gregory D.Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africa[J]. Environmental Health Perspectives . 2008 (11) 被引量:2
  • 7Buti M, Oyagiiez I, Lozano V, et al. Cost effectiveness of first- line oral antiviral therapies for chronic hepatitis B: a systematic review[J]. Pharmacoeconomies, 2013, 31 (1): 63-75. 被引量:1
  • 8Sung JJ, Tsoi KK, Wong VW, et al. Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma[J]. Aliment Pharmacol Ther, 2008, 28(9): 1067-1077. 被引量:1
  • 9Wong GL, Wong VW, Chan HY, et al. Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years[J]. Aliment Pharmacol Ther, 2012, 35(11): 1326- 1335. 被引量:1
  • 10Do,an 13/3, Kara B, Giimiirdiilfi Y, et al. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B[J]. Turk J Gastroenterol, 2012, 23 (3): 247-252. 被引量:1

共引文献154

同被引文献59

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部